American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: http://www.sciepub.com/journal/ajidm Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
Go
American Journal of Infectious Diseases and Microbiology. 2016, 4(3), 56-60
DOI: 10.12691/ajidm-4-3-2
Open AccessArticle

The Role of APACHE-II Score in Predicting Acinetobacter baumannii Colonization/Infection and Its Antimicrobial Resistance Pattern in Indonesian Teaching Hospital

Ian Huang1, Gregoey Joey1, Cucunawangsih2, and Oloan E. Tampubolon3

1Faculty of Medicine, University of Pelita Harapan, Tangerang, Indonesia

2Department of Microbiology, Faculty of Medicine, University of Pelita Harapan, Tangerang, Indonesia

3Intensive Care Unit, Siloam Hospital Lippo Village, Tangerang, Indonesia

Pub. Date: May 28, 2016

Cite this paper:
Ian Huang, Gregoey Joey, Cucunawangsih and Oloan E. Tampubolon. The Role of APACHE-II Score in Predicting Acinetobacter baumannii Colonization/Infection and Its Antimicrobial Resistance Pattern in Indonesian Teaching Hospital. American Journal of Infectious Diseases and Microbiology. 2016; 4(3):56-60. doi: 10.12691/ajidm-4-3-2

Abstract

Background: A first precautionary action against Acinetobacter baumannii (A.baumanii) can be conducted by identifying well-established risk factors of colonization/infection of that pathogen, such as underlying severity of illness. There are hardly any studies regarding the role of APACHE-II score in predicting risk of A.baumannii colonization/infection in Indonesia. Materials and Methods: A retrospective, case control investigation was performed with medical and microbiology records of ICU patients in an Indonesian Teaching Hospital from January 2013 to December 2014. Results: There were 39 patients with A.baumannii colonization/infection and 59 patients with non-A.baumannii colonization/infection enrolled in this study. Patients with A.baumannii colonization/infection had a significantly higher APACHE II score than non-Acinetobacter group, 25.7 and 23.1 (p=0.038), respectively. APACHE II score ≥ 23 had 74.4% sensitivity and 50.8 specificity to A.baumannii colonization/infection [odd ratio (OR) 3.00, 95% confidence interval (CI) 1.24-7.24, p=0.013], on the other hand APACHE II ≥ 27 had a 53.8% sensitivity and 78.0% specificity (OR 3.75, 95% CI 1.57-8.95, p=0.002). The highest susceptibility level of antibiotics against A.baumannii in this study was shown by tigecycline (82.1%) and amikacin (84.6%). Conclusions: APACHE-II score was strongly correlated with A.baumannii colonization/infection and a cut-off value of APACHE II score ≥ 23 may be used to depict increased moderate risk of A.baumannii colonization/infection. While the use carbapenem against A. baumannii infection was not recommended, tigecycline and amikacin may be considered as antibiotics of choice in treating A.baumannii infection in our hospital setting.

Keywords:
A.baumanii APACHE-II score colonization risk factors

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Fishbain, J., and A.Y. Peleg, 2010. Treatment of acinetobacter infections. Clin Infect Dis., 51 (1): 79-84.
 
[2]  Peleg, A.Y., H. Seifert, and D.L. Paterson, 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev., 21: 538-582.
 
[3]  Maragakis, L.L., and T.M. Perl, 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis., 46:1254-1263.
 
[4]  Naved, S.A., S. Siddiqui, and F.H. Khan, 2011. APACHE-II Score correlation with mortality and length of stay in an intensive care unit. J Coll Physicians Surg Pak., 21 (1): 4-8.
 
[5]  Clinical and Laboratory Standard Institute, 2014. M100-S24 Performance standards for antimicrobial susceptibility testing; Twenty-fourth informational supplement. http://ncipd.org/control/images/NCIPD_docs/CLSI_M100-S24.pdf (Accessed on October 16, 2015).
 
[6]  Manchanda, V., S. Sanchaita, and N.P. Singh, 2010. Multidrug resistant acinetobacter. J Glob Infect Dis., 2(3): 291-304.
 
[7]  Sunenshine, R.H., M.-O. Wright, L.L. Maragakis, A.D. Harris, and X. Song et al., 2007. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis., 13(1): 97-103.
 
[8]  Anunnatsiri, S., and P. Tonsawa, 2011. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. Southeast Asian J Trop Med Public Health., 42(3): 693-703.
 
[9]  Ntusi, N.B.A., M. Badri, H. Khalfey, A. Whitelaw, and S. Oliver et al., 2012. ICU-associated Acinetobacter baumannii colonization/Infection in a high HIV pprevalence resource-poor setting. PLoS ONE 7(12): e52452.
 
[10]  Jung, J.Y., M.S. Park, S.E. Kim, B.H. Park, J. Y. Son, and E.Y. Kim et al., 2010. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis., 10: 228.
 
[11]  Emine, A.L.P., M. Yerer, S. Kocagö, G. Metan, and D. Esel et al., 2009. The risk factors and spread of multidrug-resistant Acinetobacter baumannii in intubated patients in a medical intensive care unit. Turk J Med Sci. May., 39 (5): 761-769.
 
[12]  McGee S., 2002. Simplifying likelihood ratios. J Gen Intern Med., 17(8): 647-650.
 
[13]  Lee, Y.T., S.C. Kuo, S.P. Yang, Y.T. Lin, and F.C. Tseng et al., 2012. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis., 55 (2): 209-215.
 
[14]  Dent L.L., D.R. Marshall, S. Pratap, and R.B. Hulette, 2010. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis., 10: 196.
 
[15]  Paterson D.L., 2006. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis., 43 (S2): S43-S48.
 
[16]  Magiorakos, A.-P., A. Srivasan, R.B. Carey, Y. Carmeli, and M.E. Falagas et al., 2011. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect., 18: 268-281.
 
[17]  Tjoa. E., L.H. Moehario, A. Rukmana, and R. Rohsiswatmo, 2013. Acinetobacter baumannii: Role in blood stream infection in neonatal unit, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Int J Microbiol., 180763.
 
[18]  Mahajan. G., S. Sheemar, S. Chopra, J. Kaur, and D. Chowdhary et al., 2011. Carbapenem resistance and phenotypic detection of carbapenemases in clinical isolates of Acinetobacter baumannii. Indian J Med Sci., 65 (1):18-25.
 
[19]  Lemos, E.V., F.P. de la Hoz, T.R. Einarson, W.F. McGhan, and E. Quevedo et al., 2014. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect., 20: 416-423.